IRF1 and esophageal squamous cell carcinoma: Treatment with CsnB reduced ESCC tumor growth, but both rapid growth and increased tumor size demonstrated that exogenous expression of IRF1 could considerably diminish the anticancer impact of CsnB in vivo (Fig. 5E–G).